Lindbrook Capital’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$107K Buy
1,831
+841
+85% +$57K 0.01% 647
2024
Q4
$71.3K Buy
990
+42
+4% +$3.08K 0.01% 670
2024
Q3
$75.8K Sell
948
-7
-0.7% -$526 0.01% 648
2024
Q2
$68.4K Sell
955
-9
-0.9% -$662 0.01% 668
2024
Q1
$67.9K Buy
964
+43
+5% +$3.08K 0.01% 668
2023
Q4
$71.1K Buy
921
+177
+24% +$11.7K 0.01% 630
2023
Q3
$50.6K Sell
744
-109
-13% -$8.61K 0.01% 685
2023
Q2
$69.6K Buy
853
+73
+9% +$5.87K 0.01% 598
2023
Q1
$57.9K Buy
780
+196
+34% +$15.1K 0.01% 641
2022
Q4
$48.4K Buy
584
+80
+16% +$6.35K 0.01% 708
2022
Q3
$36K Sell
504
-8
-2% -$691 0.01% 766
2022
Q2
$44K Sell
512
-32
-6% -$3K 0.01% 709
2022
Q1
$59K Buy
544
+16
+3% +$1.65K 0.01% 636
2021
Q4
$68K Buy
528
+52
+11% +$6.38K 0.01% 622
2021
Q3
$58K Buy
476
+16
+3% +$1.95K 0.02% 404
2021
Q2
$52K Sell
460
-32
-7% -$3.37K 0.01% 467
2021
Q1
$47K Buy
492
+48
+11% +$4.38K 0.01% 470
2020
Q4
$35K Buy
444
+8
+2% +$579 0.01% 511
2020
Q3
$27K Buy
436
+8
+2% +$520 0.01% 528
2020
Q2
$28K Hold
428
0.01% 513
2020
Q1
$20K Buy
428
+16
+4% +$800 0.01% 547
2019
Q4
$23K Hold
412
0.01% 693
2019
Q3
$20K Hold
412
0.01% 721
2019
Q2
$21K Hold
412
0.01% 685
2019
Q1
$20K Hold
412
0.01% 700
2018
Q4
$14K Buy
+412
New +$17.2K 0.01% 738

Other funds holding TECH

Lindbrook Capital's TECH Position: Q1 2025 in Review

Lindbrook Capital increased its Bio-Techne (TECH) stake by 85% in Q1 2025, buying an estimated $57K and bringing the position to 1,831 shares worth $107K. The position accounts for 0.01% of the portfolio, ranked #647.

Lindbrook Capital first reported a position in TECH in Q4 2018 and has held it in 26 quarters since. 578 funds tracked by Wall St. Rank hold TECH as of Q1 2025.

  • Lindbrook Capital held 1,831 shares of Bio-Techne worth $107K as of Q1 2025.
  • Lindbrook Capital bought 841 Bio-Techne shares in Q1 2025, an estimated $57K.
  • Bio-Techne made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #647 holding.
  • Lindbrook Capital first reported a position in Bio-Techne in Q4 2018 and has held it in 26 quarters since.
  • 578 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.